Immunomodulatory effects of Mepolizumab on group 2 innate lymphoid cells in patients with refractory chronic cough and eosinophilic airways disease (MUCOSA) - Amsterdam 2025

Clinical insights into mechanisms defining airways disease pathogenesis and responsiveness to therapeutics

Chair(s): Cindy Barnig, Roma Sehmi

Session type: Poster session

Immunomodulatory effects of Mepolizumab on group 2 innate lymphoid cells in patients with refractory chronic cough and eosinophilic airways disease (MUCOSA)

Takahiro Matsuyama

EVENTS HOME

Poster
Abstract

Previous presentation

Next presentation

Session content

Neurophenotyping cough in respiratory disease

Jenny King

Poster

Abstract

Evidence of a local negative feedback mechanism via IL-5R? shedding from airway eosinophils.

James Melhorn

Poster

Abstract

Morphological and fractal analysis of monocytes and neutrophils from smokers and ex-smokers

Amanda Carvalho

Poster

Abstract

Increased alveolar eosinophils in chronic obstructive pulmonary disease

Sophie Booth

Poster

Abstract

Distribution of Type-2 Airway Inflammation Across Different Lung Function Status

Wuping Bao

Poster

Abstract

Elevated exTreg Cells in COPD: A Novel Immunological Landscape and Potential Therapeutic Target

Jia Hou

Poster

Abstract

Changes in airway structure/function with benralizumab treatment of severe eosinophilic asthma (SEA) observed with Functional Respiratory Imaging (FRI)

Donna Carstens

Poster

Abstract

Resident and inflammatory eosinophils in early and late onset asthma.

Umberto Semenzato

Poster

Abstract

Blood eosinophil gene expression and cytokine response is altered with anti-IL-5 Mepolizumab

Katie Raby

Poster

Abstract

Immunomodulatory effects of Mepolizumab on group 2 innate lymphoid cells in patients with refractory chronic cough and eosinophilic airways disease (MUCOSA)

Takahiro Matsuyama

Poster

Abstract

The relationship between PTPRH and CEACAM5 and Th17 immune response in severe asthma patients.

Fengjia Chen

Poster

Abstract

The effect of dupilumab therapy on T regulatory cells exhaustion state in severe asthma

Tommaso Pianigiani

Poster

Abstract

Differential impact of T2 pathway biologics on IL5R-expressing mast cell progenitors in severe asthma

Michael Fricker

Poster

Abstract

The relationship between atopy, IgE levels and response to tezepelumab in severe asthma

Francesca Cefaloni

Poster

Abstract

Effects of benralizumab on T cell adhesion molecules in severe eosinophilic asthma: modulation by IL-25 and IL-33

Irene Paggi

Poster

Abstract

IL-33 and IL-25 as drivers of ICAM1 and ICAM3 expression in Th2 and regulatory T cell subsets in severe eosinophilic asthmatic patients.

Laura Bergantini

Poster

Abstract

Increased IL-33+ and ST2+ alveolar macrophages in COPD

Sophie Booth

Poster

Abstract

The lack of response to Omalizumab in patients with severe asthma is associated with IgE receptor mutations.

Fatma Emre Turan Tasolar

Poster

Abstract

The airway transcriptome in type2 cytokine biomarker-high, -intermediate and -low severe asthma

Jiashu Shen

Poster

Abstract

Factors Influencing the Response to Allergen Immunotherapy: A Retrospective Study

Yosra Bellil

Poster

Abstract

CDN Connection Issue

The ERS Congress 2025, Amsterdam

#{title}